
    
      The primary efficacy endpoint was objective response rate, defined as the proportion of
      patients with a response of CR + PR.

      Duration of response, time to progression, and overall survival were analyzed. Descriptive
      statistics were used for demographics, disease characteristics, treatment exposures,
      efficacy, and safety variables.
    
  